CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Clinical trials for CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to improve control of chronic myeloid leukemia
Disease control Recruiting nowThis study is testing whether adding a chemotherapy drug (ASTX727) to a standard targeted therapy (dasatinib) can better control chronic myeloid leukemia (CML) in people newly diagnosed. About 70 adults with a specific genetic form of CML will receive both drugs. The goal is to s…
Matched conditions: CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Does your personality affect how well you take your cancer pills?
Knowledge-focused Recruiting nowThis study explores whether a person's personality traits influence how consistently they take their daily oral medication for chronic myeloid leukemia (CML). Researchers will observe 75 adults with CML who are already on standard therapy. The goal is to better understand barrier…
Matched conditions: CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC